Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+44.6%
5Y CAGR+47.4%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+44.6%/yr
vs +56.6%/yr prior
5Y CAGR
+47.4%/yr
Consistent
Acceleration
-12.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
7x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$522.19M+53.6%
2024$339.89M+50.0%
2023$226.62M+31.3%
2022$172.62M+58.7%
2021$108.78M+45.0%
2020$75.02M+39.4%
2019$53.83M+87.5%
2018$28.71M+214.6%
2017$9.13M+51.0%
2016$6.04M-